Suchergebnisse - "O3J8G9O825"

PubPharm (4.581)

41

Characteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Gentry, C. | Nguyen, P. | Thind, S. | +2

42

Public Health Impact of Paxlovid as Treatment for COVID-19, United States

enthalten in: Emerging infectious diseases | 2024

von Bai, Y. | Du, Z. | Wang, L. | +7

UpdateOf: medRxiv. 2023 Sep 07;:. - PMID 37732213

43

Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China : a multicentre, retrospective cohort study

enthalten in: Annals of medicine | 2024

von Han, X. | Li, C. | Yuan, X. | +22

44

Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2024

von Carlson, J. | Foos, V. | Kasle, A. | +7

45

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1 : week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

enthalten in: The lancet. HIV | 2024

von Orkin, C. | Molina, J. | Cahn, P. | +112

46

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19 : a retrospective cohort study

enthalten in: Scientific reports | 2024

von Chen, M. | Jiang, D. | Rang, J. | +2

47

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

48

Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2024

von Brosh-Nissimov, T. | Ma'aravi, N. | Leshin-Carmel, D. | +5

49

Advanced 3D Electrospinning "Xspin" System : Fabrication of Bifiber Floating Oral Pharmaceutical Scaffolds for Controlled Drug Delivery

enthalten in: Molecular pharmaceutics | 2024

von Darwesh, A. | Zhang, Y. | Aghda, N. | +2

50

Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review

enthalten in: Infection | 2024

von Fernández-de-Las-Peñas, C. | Torres-Macho, J. | Catahay, J. | +8

ErratumIn: Infection. 2024 Mar 7;:. - PMID 38451416